Anti-BRAF (phospho T401) antibody [EPR2208Y]
- 20ul selling size
- RabMAb
- Recombinant
- What is this?
5
(1 Review)
|
(8 Publications)
Rabbit Recombinant Monoclonal BRAF phospho T401 antibody. Suitable for WB and reacts with Rat samples. Cited in 8 publications.
View Alternative Names
BRAF1, RAFB1, BRAF, Serine/threonine-protein kinase B-raf, Proto-oncogene B-Raf, p94, v-Raf murine sarcoma viral oncogene homolog B1
- WB
Unknown
Western blot - Anti-BRAF (phospho T401) antibody [EPR2208Y] (AB68215)
All lanes:
Western blot - Anti-BRAF (phospho T401) antibody [EPR2208Y] (ab68215) at 1/5000 dilution
Lane 1:
PC-12 cell lysates (cells were untreated) at 10 µg
Lane 2:
PC-12 cell lysates (cells were treated with TPA) at 10 µg
Secondary
All lanes:
HRP labelled goat anti-rabbit at 1/2000 dilution
Predicted band size: 84 kDa
Observed band size: 85 kDa
false
Related conjugates and formulations (1)
-
Anti-BRAF (phospho T401) antibody [EPR2208Y] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (8)
Recent publications for all applications. Explore the full list and refine your search
Communications biology 7:1073 PubMed39217250
2024
Applications
Unspecified application
Species
Unspecified reactive species
American journal of cancer research 13:638-653 PubMed36895965
2023
Applications
Unspecified application
Species
Unspecified reactive species
Communications biology 4:688 PubMed34099862
2021
Applications
Unspecified application
Species
Unspecified reactive species
BMC gastroenterology 21:86 PubMed33622273
2021
Applications
Unspecified application
Species
Unspecified reactive species
Acta pharmaceutica Sinica. B 9:294-303 PubMed30976491
2019
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 15:6225-6232 PubMed29849782
2018
Applications
Unspecified application
Species
Unspecified reactive species
Neuroscience 372:192-212 PubMed29292072
2018
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular biochemistry 119:2864-2874 PubMed29073728
2017
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com